US Stock MarketDetailed Quotes

VCYT Veracyte

Watchlist
  • 20.120
  • -0.910-4.33%
Close May 8 16:00 ET
  • 20.120
  • 0.0000.00%
Post 16:20 ET
1.54BMarket Cap-21634P/E (TTM)

About Veracyte Company

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.

Company Profile

SymbolVCYT
Company NameVeracyte
Listing DateOct 30, 2013
Issue Price13.00
Founded2006
CEOMr. Marc A. Stapley
MarketNASDAQ
Employees815
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address6000 Shoreline Court,Suite 300
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-243-6300
Websitehttp://www.veracyte.com

Company Executives

  • Name
  • Position
  • Salary
  • Marc A. Stapley
  • Chief Executive Officer and Director
  • 7.18M
  • Annie McGuire
  • General Counsel and Chief People Officer
  • 2.48M
  • Dr. Phillip G. Febbo, M.D.
  • Chief Scientific and Chief Medical Officer
  • 3.79M
  • Dr. John Leite
  • Chief Commercial Officer, CLIA
  • 1.92M
  • Rebecca Chambers
  • Chief Financial Officer
  • 2.78M
  • Jonathan Wygant
  • Chief Accounting Officer
  • --
  • Dr. Robert S. Epstein, M.D.,M.S.
  • Chairman of the Board
  • 337.98K
  • Dr. Eliav Barr, M.D.
  • Independent Director
  • 294.98K
  • Evan Jones
  • Independent Director
  • 314.98K
  • John L. Bishop
  • Independent Director
  • 297.85K
  • Muna Bhanji
  • Independent Director
  • 299.98K
  • Jens Holstein
  • Independent Director
  • 327.47K
  • Karin Eastham
  • Independent Director
  • 314.98K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg